Macquarie To Buy Sal. Oppenheim Sales and Research Biz

© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Macquarie To Buy Sal. Oppenheim Sales and Research Biz

Macquarie Group has agreed to buy Sal. Oppenheim’s cash equities sales and research business, as it further expands its derivative operations in Europe.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • 4 capital markets databases
  • Daily newsletters across markets and asset classes
  • 2 weekly podcasts

Related articles

Gift this article